Phase II study of temozolomide plus pegylated interferon-alpha-2b for metastatic melanoma.
Hwu WJ, Panageas KS, Menell JH, Lamb LA, Aird S, Krown SE, Williams LJ, Chapman PB, Livingston PO, Wolchok JD, Houghton AN.
Hwu WJ, et al. Among authors: panageas ks.
Cancer. 2006 Jun 1;106(11):2445-51. doi: 10.1002/cncr.21909.
Cancer. 2006.
PMID: 16639739
Free article.
Clinical Trial.